Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RA-DRUM
NCT06440629Phase 4Active, not recruiting
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Aug 2024
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Diakonhjemmet Sykehus. Started Aug 2024; status: active, not recruiting.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06440629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440629.